At DuPont, we are closely monitoring the COVID-19 pandemic and taking steps to manage the impacts to our people, locations and production. We do this through the activation of both corporate and local crisis management teams, ensuring that we can give global guidance and act locally depending on the situation.
In line with our Core Values, the safety and well-being of our employees and customers as well as ensuring the highest product quality and safety are key priorities for us. We are implementing safety plans and protocols based on World Health Organization (WHO) and Centers for Disease Control (CDC) guidelines and recommendations to help prevent the spread of the virus.
Following these guidelines, we have issued several strong measures to contain and mitigate the spread of infection at our sites and offices. These include
- Suspending international travel and restricting all other travel to business-critical only.
- Mandatory self-quarantine measures for employees at risk of exposure.
- Limiting access to our sites.
- Conducting enhanced and more frequent cleaning services at all facilities.
- Encouraging employees to practice social distancing, proper handwashing and hygiene practices.
- Canceling participation at all large meetings, both internally and externally.
- Requiring employees to work from home where possible.
In our Nutrition & Biosciences business, we continue to run our production at sites across the world, ensuring delivery of essential products to customers. As a business supplying critical industries, we have preferential status in many countries, which helps us in ensuring shipment of products.
All our manufacturing plants are up and running and have been able to mitigate temporary shortages of supply of raw material. They continue to produce and ship products meeting the highest standards of product safety and quality. Although we experience logistic challenges in some countries and regions, we are shipping products from all our plants to meet customers’ needs.
We continue to assess the situation, monitor the availability of raw materials and adjust actions and plans as needed. Unless you hear otherwise from us, you can assume that your product orders will be delivered on time. Should we experience disruption or delays in delivering dates, your DuPont Nutrition & Biosciences account team will be in contact with you at the earliest opportunity. In this event, we appreciate your understanding and flexibility.
Amy Byrick – Food & Beverage Leader
Simon Herriott – Health & Biosciences Leader
Angela Strzelecki – Health & Biosciences Leader Pharma Solutions Leader